Computer Adaptation of Screening, Brief MET Intervention to Reduce Teen Drinking
NCT ID: NCT01881841
Last Updated: 2017-04-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
150 participants
INTERVENTIONAL
2015-01-31
2017-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pilot Test of Computerized MET to Reduce Adolescent Alcohol Use
NCT01796158
Trial of Computerized MET for Adolescent Substance Use
NCT01784653
Family Based Contingency Management for Adolescent Alcohol Abuse
NCT00595478
Development and Testing of Adolescent Twelve-Step Facilitation
NCT01449981
Brief Alcohol Intervention for Adolescents Who Have Attempted Suicide
NCT02426957
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Assess cMET feasibility and acceptability and estimate its effect size on underage drinking. Hypothesis: Among 14- to 20-yr-old primary care patients, those receiving cMET will have lower rates of any alcohol use, days of alcohol use, drinks per drinking day, and days of heavy episodic drinking, than those receiving treatment as usual.
2. Estimate effect sizes for tobacco, cannabis, and other drug use, and other substance-related risks and outcomes including substance-related driving/riding, and experience of substance-related problems.
3. Identify potential moderators and mediators of cMET's effect.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment As Usual
Those randomized to Treatment as Usual (TAU) will not complete cMET but will receive standard treatment from the doctor.
No interventions assigned to this group
cMET
Those randomized to cMET will complete a 2-session computerized Motivational Enhancement Therapy (cMET) intervention.
cMET
Those in cMET complete the 2-session self-administered computerized intervention which includes 8 exercises designed to encourage adolescents to evaluate the impact of alcohol and other substance use on their health and well-being and consider changing their use.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cMET
Those in cMET complete the 2-session self-administered computerized intervention which includes 8 exercises designed to encourage adolescents to evaluate the impact of alcohol and other substance use on their health and well-being and consider changing their use.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* arriving for routine care to one of our participating pediatric practices (Lexington Pediatrics, Lexington, MA; East Boston Community Health Center, Longwood Pediatrics, Tufts Medical Center Adolescent Clinic, Boston, MA; Cambridge Health Alliance Dept. of Pediatrics, Cambridge, MA)
* any alcohol use days in the past 90 days,
* have an email address and internet access at home, school, or library
* provide informed assent/consent.
Exclusion Criteria
* living away at college at the time of the recruitment visit,
* not available for computer/telephone follow-ups,
* judged by the provider to be medically or emotionally unstable at the time of the visit.
14 Years
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boston Children's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sion Kim Harris
Assistant Professor of Pediatrics, Harvard Medical School; Co-Director, Center for Adolescent Substance Abuse Research, Boston Children's Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John R Knight, MD
Role: PRINCIPAL_INVESTIGATOR
Boston Children's Hospital
Sion K Harris, PhD
Role: PRINCIPAL_INVESTIGATOR
Boston Children's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Boston Children's Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
Web site of the Center for Adolescent Substance Abuse Research at Boston Children's Hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JRKnightR34PA-13-078
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.